anuj237
Cancer-Cachexia-Market-Analysis
Cancer Cachexia Market
Cancer cachexia is a wasting syndrome, which is characterized by weight loss, anorexia (loss of desire to eat), asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
cachexia occurs in the majority of terminal cancer patients and is responsible for the death of 22% of cancer patients [As per a Japanese study conducted by Aoyagi et al.].
Among late stage patients, cachexia affects 50–80% of cancer patients
According to a study conducted by Advani et al., “cancer cachexia impacts approximately 60% of the 1.4 million patients diagnosed with cancer in the United States each year.
For more details on Cancer Cachexia Market, visit:
www.delveinsight.com/report-store/cancer-cachexia-market
Cancer-Cachexia-Market-Analysis
Cancer Cachexia Market
Cancer cachexia is a wasting syndrome, which is characterized by weight loss, anorexia (loss of desire to eat), asthenia and anemia. The pathogenicity of this syndrome is multifactorial, due to a complex interaction of tumor and host factors.
cachexia occurs in the majority of terminal cancer patients and is responsible for the death of 22% of cancer patients [As per a Japanese study conducted by Aoyagi et al.].
Among late stage patients, cachexia affects 50–80% of cancer patients
According to a study conducted by Advani et al., “cancer cachexia impacts approximately 60% of the 1.4 million patients diagnosed with cancer in the United States each year.
For more details on Cancer Cachexia Market, visit:
www.delveinsight.com/report-store/cancer-cachexia-market